Pharmaceutical News Russian antitumor drugs first time received a registration certificate in Europe March 31, 2020March 31, 2020 Two BIOCAD products, Acellbia (INN: rituximab) and Herticad (INN: trastuzumab), received the first European registration certificate in Bosnia and Herzegovina. More